Print Page  |  Close Window

SEC Filings

424B5
PROTAGONIST THERAPEUTICS, INC filed this Form 424B5 on 08/07/2018
Entire Document
 

Table of Contents

 

2,750,000 Shares

LOGO

Common Stock

PROSPECTUS SUPPLEMENT

August 7, 2018